|
J Biol Chem, Vol. 273, Issue 37, 24181-24189, September 11, 1998
High Constitutive Activity of the Human Formyl Peptide
Receptor
Katharina
Wenzel-Seifert,
Carl M.
Hurt, and
Roland
Seifert
From the Howard Hughes Medical Institute, Stanford University
Medical School, Stanford, California 94305-5428
The formyl peptide receptor (FPR) couples to
pertussis toxin (PTX)-sensitive Gi-proteins to
activate chemotaxis and exocytosis in neutrophils. PTX reduces not only
formyl peptide-stimulated but also agonist-independent ("basal")
Gi-protein activity, suggesting that the FPR is
constitutively active. We aimed at identifying an inverse FPR agonist,
i.e. a compound that suppresses constitutive FPR activity.
In Sf9 insect cell membranes, the G-protein heterotrimer Gi 2 1 2
reconstituted
N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-stimulated guanosine 5'-O-(3-thiotriphosphate)
(GTP S) binding and GTP S-sensitive high affinity
[3H]FMLP binding. The FPR "antagonist" cyclosporin H
(CsH) potently and efficiently reduced basal GTP S binding
in Sf9 membranes. Another FPR antagonist,
N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine did not inhibit basal GTP S binding but blocked the inhibitory effect
of CsH on GTP S binding. Na+ reduced basal GTP S
binding and eliminated the inhibitory effect of CsH. Similar effects of
FMLP, CsH, and Na+ as in Sf9 membranes were observed
with FPR expressed in the mammalian cell line HEK293. Our data show
that the human FPR possesses high constitutive activity. CsH is an
inverse FPR agonist and stabilizes the FPR in an inactive state.
Na+ also stabilizes the FPR in an inactive state and,
thereby, diminishes inverse agonist efficacy.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev.,
June 1, 2009;
61(2):
119 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cheng, R. He, J. Tian, M. C. Dinauer, and R. D. Ye
A Critical Role of Protein Kinase C{delta} Activation Loop Phosphorylation in Formyl-Methionyl-Leucyl-Phenylalanine-Induced Phosphorylation of p47phox and Rapid Activation of Nicotinamide Adenine Dinucleotide Phosphate Oxidase
J. Immunol.,
December 1, 2007;
179(11):
7720 - 7728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yan, M. Nanamori, M. Sun, C. Zhou, N. Cheng, N. Li, W. Zheng, L. Xiao, X. Xie, R. D. Ye, et al.
The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding
J. Immunol.,
November 15, 2006;
177(10):
7050 - 7058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bastian, B. Posch, K. Lang, B. Niggemann, K. S. Zaenker, H. Hatt, and F. Entschladen
Phosphatidylinositol 3-Kinase in the G Protein-Coupled Receptor-Induced Chemokinesis and Chemotaxis of MDA-MB-468 Breast Carcinoma Cells: A Comparison with Leukocytes
Mol. Cancer Res.,
June 1, 2006;
4(6):
411 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F. W. Rossi, V. Visconte, G. Rossi, G. Marone, and P. Ragno
Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2
J. Immunol.,
November 1, 2004;
173(9):
5739 - 5748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. de Paulis, N. Prevete, I. Fiorentino, A. F. Walls, M. Curto, A. Petraroli, V. Castaldo, P. Ceppa, R. Fiocca, and G. Marone
Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2-20)
J. Immunol.,
June 15, 2004;
172(12):
7734 - 7743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Postma, M. J. Poppelier, J. C. van Galen, E. R. Prossnitz, J. A. G. van Strijp, C. J. C. de Haas, and K. P. M. van Kessel
Chemotaxis Inhibitory Protein of Staphylococcus aureus Binds Specifically to the C5a and Formylated Peptide Receptor
J. Immunol.,
June 1, 2004;
172(11):
6994 - 7001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kenakin
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Mol. Pharmacol.,
January 1, 2004;
65(1):
2 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gille and R. Seifert
2'(3')-O-(N-Methylanthraniloyl)-substituted GTP Analogs: A Novel Class of Potent Competitive Adenylyl Cyclase Inhibitors
J. Biol. Chem.,
April 4, 2003;
278(15):
12672 - 12679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. de Paulis, G. Florio, N. Prevete, M. Triggiani, I. Fiorentino, A. Genovese, and G. Marone
HIV-1 Envelope gp41 Peptides Promote Migration of Human Fc{epsilon}RI+ Cells and Inhibit IL-13 Synthesis Through Interaction with Formyl Peptide Receptors
J. Immunol.,
October 15, 2002;
169(8):
4559 - 4567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Berger, S. Budhu, E. Lu, Y. Li, D. Loike, S. C. Silverstein, and J. D. Loike
Different Gi-coupled chemoattractant receptors signal qualitatively different functions in human neutrophils
J. Leukoc. Biol.,
May 1, 2002;
71(5):
798 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Graham, E. R. Prossnitz, and R. I. Dorin
Dexras1/AGS-1 Inhibits Signal Transduction from the Gi-coupled Formyl Peptide Receptor to Erk-1/2 MAP Kinases
J. Biol. Chem.,
March 22, 2002;
277(13):
10876 - 10882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Seifert and K. Wenzel-Seifert
Defective Gi Protein Coupling in Two Formyl Peptide Receptor Mutants Associated with Localized Juvenile Periodontitis
J. Biol. Chem.,
November 2, 2001;
276(45):
42043 - 42049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wenzel-Seifert and R. Seifert
Molecular Analysis of beta 2-Adrenoceptor Coupling to Gs-, Gi-, and Gq-Proteins
Mol. Pharmacol.,
November 1, 2000;
58(5):
954 - 966.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Brys, K. Josson, M. P. Castelli, M. Jurzak, P. Lijnen, W. Gommeren, and J. E. Leysen
Reconstitution of the Human 5-HT1D Receptor-G-Protein Coupling: Evidence for Constitutive Activity and Multiple Receptor Conformations
Mol. Pharmacol.,
June 1, 2000;
57(6):
1132 - 1141.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Dahlgren, T. Christophe, F. Boulay, P. N. Madianos, M. J. Rabiet, and A. Karlsson
The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A4 receptor
Blood,
March 1, 2000;
95(5):
1810 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Miettinen, J. M. Gripentrog, M. M. Mason, and A. J. Jesaitis
Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein
J. Biol. Chem.,
September 24, 1999;
274(39):
27934 - 27942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Seifert, U. Gether, K. Wenzel-Seifert, and B. K. Kobilka
Effects of Guanine, Inosine, and Xanthine Nucleotides on beta 2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations
Mol. Pharmacol.,
August 1, 1999;
56(2):
348 - 358.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. S. Mills, H. M. Miettinen, D. Cummings, and A. J. Jesaitis
Characterization of the Binding Site on the Formyl Peptide Receptor Using Three Receptor Mutants and Analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu
J. Biol. Chem.,
December 8, 2000;
275(50):
39012 - 39017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2
J. Biol. Chem.,
June 8, 2001;
276(24):
21585 - 21593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Cordeaux, S. A. Nickolls, L. A. Flood, S. G. Graber, and P. G. Strange
Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction. EVIDENCE FOR AGONIST SELECTION OF G PROTEIN SUBTYPE
J. Biol. Chem.,
July 27, 2001;
276(31):
28667 - 28675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Holst, H. Hastrup, U. Raffetseder, L. Martini, and T. W. Schwartz
Two Active Molecular Phenotypes of the Tachykinin NK1 Receptor Revealed by G-protein Fusions and Mutagenesis
J. Biol. Chem.,
June 1, 2001;
276(23):
19793 - 19799.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|